Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6

1267-1272, 2000. [2] (multiple letters)

Frederick J Meyers, G. C. De Gast

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)4167
Number of pages1
JournalClinical Cancer Research
Volume6
Issue number10
StatePublished - 2000

Fingerprint

Combined Modality Therapy
Kidney Neoplasms
Granulocyte-Macrophage Colony-Stimulating Factor
Renal Cell Carcinoma
Interferon-alpha
Immunotherapy
Interleukin-2
Melanoma
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{1773998921ef47bd97afbf3b37029f59,
title = "Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000. [2] (multiple letters)",
author = "Meyers, {Frederick J} and {De Gast}, {G. C.}",
year = "2000",
language = "English (US)",
volume = "6",
pages = "4167",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6

T2 - 1267-1272, 2000. [2] (multiple letters)

AU - Meyers, Frederick J

AU - De Gast, G. C.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0034304202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034304202&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 4167

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 10

ER -